IMMUNEERING CORPORATIO
2.4600
07-October-24 15:59:56
15 minutes delayed
Stocks
-0.0100
-0.40%
Today's range
2.3700 - 2.6000
ISIN
N/A
Source
NASDAQ
-
Immuneering Reports Third Quarter 2023 Financial Results and Provides Business Updates
09 Nov 2023 16:05:01 By Nasdaq GlobeNewswire
-
12 Oct 2023 16:05:00 By Nasdaq GlobeNewswire
-
04 Oct 2023 16:05:00 By Nasdaq GlobeNewswire
-
Immuneering to Present at the Morgan Stanley Healthcare Conference
06 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
Immuneering Reports Second Quarter 2023 Financial Results and Provides Business Updates
03 Aug 2023 16:05:01 By Nasdaq GlobeNewswire
-
05 Jun 2023 08:00:01 By Nasdaq GlobeNewswire
-
Immuneering to Present at the Jefferies Healthcare Conference
30 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
Immuneering Reports First Quarter 2023 Financial Results and Provides Business Updates
04 May 2023 16:05:02 By Nasdaq GlobeNewswire
-
Immuneering Announces $30 Million Underwritten Offering
18 Apr 2023 09:24:15 By Nasdaq GlobeNewswire
-
18 Apr 2023 09:00:02 By Nasdaq GlobeNewswire
-
Immuneering to Present at the 22nd Annual Needham Virtual Healthcare Conference
12 Apr 2023 16:05:00 By Nasdaq GlobeNewswire
-
Immuneering Appoints Harold E. Brakewood as Chief Business Officer
28 Mar 2023 08:00:01 By Nasdaq GlobeNewswire
-
14 Mar 2023 16:30:00 By Nasdaq GlobeNewswire
-
06 Mar 2023 16:05:00 By Nasdaq GlobeNewswire
-
Immuneering Presents Preclinical Data with Lead Program IMM-1-104 Supporting Universal-RAS Activity
05 Mar 2023 18:30:00 By Nasdaq GlobeNewswire
-
Immuneering Announces Participation in March Investor Conferences
28 Feb 2023 08:00:02 By Nasdaq GlobeNewswire
-
Immuneering to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates
27 Feb 2023 08:00:01 By Nasdaq GlobeNewswire
-
Immuneering To Present at Guggenheim 2023 Oncology Conference
31 Jan 2023 06:50:00 By Nasdaq GlobeNewswire
-
28 Nov 2022 06:50:00 By Nasdaq GlobeNewswire